Browsing by Author "Majem Tarruella, Margarita"
Now showing items 1-6 of 6
-
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study
Isla, Dolores; Felip Font, Enriqueta; Garrido, Pilar; Majem Tarruella, Margarita; Trigo, José Manuel; de Castro Carpeno, Javier; Remon, Jordi; Insa, Amelia (Springer, 2023-01) -
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study
Viñolas, N. Nuria; Garcia‑Campelo, Rosario; Majem Tarruella, Margarita; Isla, Dolores; Gonzalez‑Larriba, José Luis; Felip Font, Enriqueta; Carcereny, Enric (BMC, 2020-11-23) -
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer
Herbst, Roy; Majem Tarruella, Margarita; Barlesi, Fabrice; Chu, Quincy; Monnet, Isabelle; Martínez Marti, Alexandre; Carcereny, Enric (American Society of Clinical Oncology, 2022-10-10) -
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Garrido, Pilar; Paz-Ares, Luis; Majem Tarruella, Margarita; Morán, Teresa; Trigo, José Manuel; Bosch-Barrera, J; Felip Font, Enriqueta (Wiley, 2021-09) -
SEOM clinical guideline for the management of cutaneous melanoma (2020)
Majem Tarruella, Margarita; Manzano, Jose Luis; Marquez‑Rodas, I.; Mujika, K.; Pérez‑Ruiz, E.; Muñoz Couselo, Eva (Springer, 2021-05) -
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
Majem Tarruella, Margarita; García‑Martínez, E.; Martinez, M.; Rodriguez‑Abreu, D.; Alvarez, R.; Muñoz Couselo, Eva (Springer, 2020-02)